NYSE:BHVN - Biohaven Pharmaceutical Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$60.16 -0.02 (-0.03 %)
(As of 04/21/2019 10:25 AM ET)
Previous Close$60.16
Today's Range$58.81 - $60.82
52-Week Range$25.60 - $62.25
Volume681,728 shs
Average Volume767,271 shs
Market Capitalization$2.66 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Biohaven Pharmaceutical (NYSE:BHVN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
9 Wall Street analysts have issued ratings and price targets for Biohaven Pharmaceutical in the last 12 months. Their average twelve-month price target is $65.3913, suggesting that the stock has a possible upside of 8.70%. The high price target for BHVN is $89.00 and the low price target for BHVN is $49.13. There are currently 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.782.892.892.83
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $65.3913$57.3750$51.50$50.00
Price Target Upside: 8.70% upside14.90% upside50.06% upside38.70% upside

Biohaven Pharmaceutical (NYSE:BHVN) Consensus Price Target History

Price Target History for Biohaven Pharmaceutical (NYSE:BHVN)

Biohaven Pharmaceutical (NYSE:BHVN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/15/2019OppenheimerBoost Price TargetOutperform ➝ Outperform$54.00 ➝ $70.00LowView Rating Details
4/15/2019Canaccord GenuityBoost Price TargetBuy ➝ Buy$46.00 ➝ $89.00MediumView Rating Details
4/9/2019Morgan StanleyDowngradeOverweight ➝ Equal Weight$49.13LowView Rating Details
3/19/2019BarclaysReiterated RatingHold$52.00MediumView Rating Details
3/18/2019Piper Jaffray CompaniesSet Price TargetBuy$75.00LowView Rating Details
3/6/2019Cantor FitzgeraldBoost Price TargetOverweight$82.00HighView Rating Details
3/4/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$48.00 ➝ $56.00MediumView Rating Details
11/15/2018William BlairReiterated RatingOutperformHighView Rating Details
11/12/2018Leerink SwannInitiated CoverageOutperform$50.00LowView Rating Details
(Data available from 4/21/2017 forward)
This page was last updated on 4/21/2019 by MarketBeat.com Staff

Featured Article: What is a Stop Order?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel